InsidersTradesSigma
신신제약 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the 신신제약 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 신신제약 has recorded 26 public disclosures. Market capitalisation: €66.4bn. The latest transaction was disclosed on 1 July 2026 (Other). Among the most active insiders: 이종민. All data is accessible without an account.
26
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 2,869 of 26,212 companies
72.9
score / 100
Value86
Quality60
FCF yld10%
Earn yld14%
EV/EBITDA6.6x
ROE16%
Gross mgn38%
Net mgn8.2%
Debt/EBITDA2.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 1 July 2026
Declarations26 total
25 of 26 declarations
About 신신제약
신신제약 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX exchange. It focuses on the development and marketing of pharmaceutical products.